{
"id":"mk19_bb_hm_s27",
"subspecialtyId":"hm",
"title":"Anemia and Thrombocytopenia in Pregnancy",
"jsonContent":{
"type":"section",
"id":"mk19_bb_hm_s27",
"title":{
"__html":"Anemia and Thrombocytopenia in Pregnancy"
},
"titleNode":{
"type":"section-title",
"hlId":"f5f333",
"children":[
"Anemia and Thrombocytopenia in Pregnancy"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_hm_s27_1",
"title":{
"__html":"Diagnosis"
},
"titleNode":{
"type":"section-title",
"hlId":"523223",
"children":[
"Diagnosis"
]
},
"children":[
{
"type":"p",
"hlId":"8094c2",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Anemia:"
]
},
" Pregnancy results in a normal dilutional anemia. Hemoglobin values less than 11 g/dL in the first trimester or less than 10 g/dL in the second and third trimesters should prompt a search for other causes of anemia; ",
{
"type":"alert",
"children":[
"iron and folate deficiency are the most common causes."
]
}
]
},
{
"type":"p",
"hlId":"77e9ae",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Thrombocytopenia:"
]
},
" The most common cause is gestational thrombocytopenia."
]
},
{
"type":"p",
"hlId":"1f2856",
"children":[
{
"type":"abbreviation",
"title":"hemolysis, elevated liver enzyme levels, and a low platelet count",
"children":[
"HELLP"
]
},
" syndrome, preeclampsia, and ",
{
"type":"abbreviation",
"title":"acute fatty liver of pregnancy",
"children":[
"AFLP"
]
},
" can cause thrombocytopenia and are part of a spectrum of disorders referred to as the “thrombotic microangiopathy of pregnancy.” Symptoms and laboratory features for each overlap. ",
{
"type":"alert",
"children":[
"Making the distinction between the disorders may not be critical, because the most effective therapy for each is emergent delivery of the fetus."
]
}
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_bb_hm_s27_inline_t1"
],
"forceOpen":true
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"b086aa",
"children":[
"Mild thrombocytopenia (platelet count >100,000/μL) occurring late in pregnancy is likely to be gestational thrombocytopenia, not ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"immune thrombocytopenic purpura",
"children":[
"ITP"
]
},
","
]
},
" and requires no therapy."
]
},
" "
]
}
]
}
]
},
"tablesContent":{
"mk19_bb_hm_s27_inline_t1":{
"id":"mk19_bb_hm_s27_inline_t1",
"number":1,
"bookId":"hm",
"title":{
"__html":"Study Table: Thrombocytopenia during Pregnancy"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"52bc37",
"children":[
"Study Table: Thrombocytopenia during Pregnancy"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"589189",
"class":"col hd l",
"children":[
"Disorder"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"93932b",
"class":"col hd l",
"children":[
"Characteristics"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"44f0ed",
"class":"cell txt l",
"children":[
"Gestational thrombocytopenia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ba807e",
"class":"cell txt l",
"children":[
"Benign thrombocytopenia typically >100,000/μL; late second or third trimester; no schistocytes on peripheral blood smear"
]
},
" ",
{
"type":"p",
"hlId":"59ad26",
"class":"cell txt l",
"children":[
"No treatment needed"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"98bd8a",
"class":"cell txt l",
"children":[
"ITP"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"91a629",
"class":"cell txt l",
"children":[
"May present early in pregnancy"
]
},
" ",
{
"type":"p",
"hlId":"d6a9e4",
"class":"cell txt l",
"children":[
"Treatment with glucocorticoids or ",
{
"type":"abbreviation",
"title":"intravenous immune globulin",
"children":[
"IVIG"
]
},
" for platelet count <30,000/μL (<50,000/μL for delivery)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7846b9",
"class":"cell txt l",
"children":[
{
"type":"abbreviation",
"title":"thrombotic thrombocytopenic purpura",
"children":[
"TTP"
]
},
"-",
{
"type":"abbreviation",
"title":"hemolytic uremic syndrome",
"children":[
"HUS"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fcffb1",
"class":"cell txt l",
"children":[
"See TTP-HUS section; develops at >20 weeks' gestation; not affected by pregnancy termination"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"029a1c",
"class":"cell txt l",
"children":[
"Preeclampsia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5a174c",
"class":"cell txt l",
"children":[
"Hypertension, proteinuria, and thrombocytopenia developing at >20 weeks' gestation"
]
},
" ",
{
"type":"p",
"hlId":"dcd0e4",
"class":"cell txt l",
"children":[
"Treatment is delivery"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"de9b49",
"class":"cell txt l",
"children":[
"HELLP syndrome"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d1b96f",
"class":"cell txt l",
"children":[
"Microangiopathic hemolytic anemia; ",
{
"type":"abbreviation",
"title":"aspartate aminotransferase",
"children":[
"AST"
]
},
" >70 U/L, platelet count <100,000/μL developing at >20 weeks' gestation"
]
},
" ",
{
"type":"p",
"hlId":"dcd0e4",
"class":"cell txt l",
"children":[
"Treatment is delivery"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"072118",
"class":"cell txt l",
"children":[
"AFLP"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b5e4f6",
"class":"cell txt l",
"children":[
"Microangiopathic hemolytic anemia, liver failure, hypoglycemia, and coagulopathy at >20 weeks' gestation"
]
},
" ",
{
"type":"p",
"hlId":"dcd0e4",
"class":"cell txt l",
"children":[
"Treatment is delivery"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bb938a",
"class":"cell txt l",
"children":[
" ",
{
"type":"abbreviation",
"title":"disseminated intravascular coagulation",
"children":[
"DIC"
]
},
" "
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3335d6",
"class":"cell txt l",
"children":[
"In setting of obstetric emergency, elevated levels of fibrin degradation products and/or D-dimers, decreased fibrinogen level, possible prolongation of the ",
{
"type":"abbreviation",
"title":"prothrombin time",
"children":[
"PT"
]
},
" and ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"activated partial thromboplastin time",
"children":[
"aPTT"
]
},
","
]
},
" and thrombocytopenia"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
}
}
}